Clinical Trial Update: Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of corneal collagen cross-linking for keratoconus or corneal ectasia after refractive surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus

Drugs mentioned

• Corneal Collagen Cross-Linking (riboflavin-mediated corneal collagen cross-linking)

Snippet

Sponsor: American-European Congress of Ophthalmic Surgery | Conditions: Keratoconus, Corneal Ectasia | Phase 3 | Status: TERMINATED